Literature DB >> 3134244

Intravenous immune globulin in symptomatic paediatric human immunodeficiency virus infection.

U B Schaad1, A Gianella-Borradori, B Perret, P Imbach, A Morell.   

Abstract

Seven paediatric patients with symptomatic human immunodeficiency virus (HIV) infection were prospectively studied for 6-24 months after the start of intravenous immune globulin (IVIG) therapy. There was substantial clinical benefit during IVIG treatment with marked reduction of febrile and infectious episodes, normalization of physical and psychomotor development, and absence of mortality. The immunologic monitoring revealed some discrete objective improvements. The results of this study favourably compare to previous reports. It is concluded that IVIG should be standard therapy for symptomatic childhood HIV infection.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3134244     DOI： 10.1007/bf00442700

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  14 in total

1.  AIDS in children: a review of the clinical, epidemiologic and public health aspects.

Authors:  M F Rogers
Journal:  Pediatr Infect Dis       Date:  1985 May-Jun

2.  Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines.

Authors:  B M Stadler; S F Dougherty; J J Farrar; J J Oppenheim
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

3.  Pulmonary disease in children with acquired immune deficiency syndrome and AIDS-related complex.

Authors:  A Rubinstein; R Morecki; B Silverman; M Charytan; B Z Krieger; W Andiman; M N Ziprkowski; H Goldman
Journal:  J Pediatr       Date:  1986-04       Impact factor: 4.406

4.  Acquired immunodeficiency syndrome (AIDS) in pediatric patients. Case report and review.

Authors:  U B Schaad; A Morell; M Vogt
Journal:  Helv Paediatr Acta       Date:  1985-09

5.  Acquired immunodeficiency syndrome in infants.

Authors:  G B Scott; B E Buck; J G Leterman; F L Bloom; W P Parks
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

6.  Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers.

Authors:  A Rubinstein; M Sicklick; A Gupta; L Bernstein; N Klein; E Rubinstein; I Spigland; L Fruchter; N Litman; H Lee; M Hollander
Journal:  JAMA       Date:  1983-05-06       Impact factor: 56.272

7.  Restoration of suppressor T-cell functions in children with AIDS following intravenous gamma globulin treatment.

Authors:  A Gupta; B E Novick; A Rubinstein
Journal:  Am J Dis Child       Date:  1986-02

8.  Serum lactate dehydrogenase levels in adults and children with acquired immune deficiency syndrome (AIDS) and AIDS-related complex: possible indicator of B cell lymphoproliferation and disease activity. Effect of intravenous gammaglobulin on enzyme levels.

Authors:  B A Silverman; A Rubinstein
Journal:  Am J Med       Date:  1985-05       Impact factor: 4.965

9.  Immune deficiency syndrome in children.

Authors:  J Oleske; A Minnefor; R Cooper; K Thomas; A dela Cruz; H Ahdieh; I Guerrero; V V Joshi; F Desposito
Journal:  JAMA       Date:  1983-05-06       Impact factor: 56.272

10.  Defective humoral immunity in pediatric acquired immune deficiency syndrome.

Authors:  L J Bernstein; H D Ochs; R J Wedgwood; A Rubinstein
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406
View more
  12 in total

Review 1.  Newer uses of intravenous immunoglobulins as anti-infective agents.

Authors:  J E Pennington
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 2.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

3.  Immunotherapy for infectious diseases.

Authors:  J E Pennington
Journal:  West J Med       Date:  1990-04

4.  Intravenous immunoglobulin in HIV infection: evidence for the efficacy of treatment.

Authors:  R A Hague; P L Yap; J Y Mok; O B Eden; N A Coutts; J G Watson; F D Hargreaves; J M Whitelaw
Journal:  Arch Dis Child       Date:  1989-08       Impact factor: 3.791

5.  Intravenous immunoglobulin in HIV infection.

Authors:  D Gibb; M Levin
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

Review 6.  Criteria for the appropriate drug utilisation of immunoglobulin.

Authors:  P Thürmann; S Harder
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

Review 7.  Intravenous immunoglobulin for secondary immunodeficiency.

Authors:  P L Yap
Journal:  Blut       Date:  1990-01

8.  Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge.

Authors:  R Hofmann-Lehmann; J Vlasak; R A Rasmussen; B A Smith; T W Baba; V Liska; F Ferrantelli; D C Montefiori; H M McClure; D C Anderson; B J Bernacky; T A Rizvi; R Schmidt; L R Hill; M E Keeling; H Katinger; G Stiegler; L A Cavacini; M R Posner; T C Chou; J Andersen; R M Ruprecht
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

9.  Hyperviscosity in HIV infected children--a potential hazard during intravenous immunoglobulin therapy.

Authors:  R A Hague; O B Eden; P L Yap; J Y Mok; P Rae
Journal:  Blut       Date:  1990 Aug-Sep

Review 10.  Does intravenous immune globulin have a role in HIV-infected patients?

Authors:  P L Yap
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.